BIRC3-HSP90B1 相互作用通过细胞外信号调节激酶通路抑制非小细胞肺癌的进展
Feng Suo1, Yuan Wu1, Qiong Zhou1
1Department of Cardiothoracic Surgery, Xuzhou Cancer Hospital, Xuzhou 221000, P.R China.
ACS omega
|May 6, 2024
概括
BIRC3是一种亡抑制剂,在非小细胞肺癌 (NSCLC) 中被下调,作为瘤抑制剂. 它与HSP90B1的相互作用抑制了癌症的进展,并改善了患者的预后.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 由于长期预后不佳,非小细胞肺癌 (NSCLC) 存在重大治疗挑战.
- 像BIRC3这样的亡抑制剂 (IAP) 蛋白与瘤调节有关,但BIRC3在NSCLC中的作用尚不清楚.
研究的目的:
- 研究BIRC3在NSCLC中的表达,预后价值和功能作用.
- 阐明BIRC3对NSCLC进展的调节背后的分子机制.
主要方法:
- 使用TCGA和GEO数据库对NSCLC组织中的BIRC3表达的分析.
- 在体外研究涉及BIRC3过度表达和在NSCLC细胞中敲击.
- 使用裸体小鼠模型进行体内验证.
- 同免疫沉 (Co-IP) 测试用于识别BIRC3相互作用蛋白.
主要成果:
- 在NSCLC组织中,BIRC3的表达显著下调.
- 较高的BIRC3表达与改善的患者预后相关.
- BIRC3抑制NSCLC细胞的增殖,迁移和入侵.
- BIRC3与HSP90B1相互作用,减少其表达并抑制ERK信号通路.
结论:
- 在NSCLC中,BIRC3作为瘤抑制剂起作用.
- BIRC3直接与HSP90B1相互作用,对ERK通路产生负面调节,从而阻碍瘤的进展.
- BIRC3有可能成为NSCLC的预后生物标志物.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.3K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
